292: Vertex's polarizing data, Aduhelm's adieu, & an FDA icon
The Readout Loud
00:00
Exit interviews and observations on FDA dynamics
Discussions on the experiences of an influential FDA figure, the changing dynamics between federal agencies and Congress, concerns about FDA regulatory powers, and a controversial decision on accelerated drug approval for Duchenne muscular dystrophy.
Transcript
Play full episode
